These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2185969)

  • 61. Effects of long term octreotide on gall stone formation and gall bladder function.
    Bigg-Wither GW; Ho KK; Grunstein RR; Sullivan CE; Doust BD
    BMJ; 1992 Jun; 304(6842):1611-2. PubMed ID: 1628089
    [No Abstract]   [Full Text] [Related]  

  • 62. Rapid determination of the p-aminobenzoic acid excretion index in urine without use of radioactivity.
    Holk FJ; Tytgat GN
    Clin Chem; 1986 Jan; 32(1 Pt 1):234-5. PubMed ID: 3484435
    [No Abstract]   [Full Text] [Related]  

  • 63. Octreotide-induced acute life-threatening gallstones after vicarious contrast medium excretion: A case report.
    Han ZH; He ZM; Chen WH; Wang CY; Wang Q
    World J Clin Cases; 2021 Sep; 9(25):7484-7489. PubMed ID: 34616816
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [EXOCRINE FUNCTION OF THE PANCREAS, CONTRACTILE FUNCTION OF THE GALLBLADDER AND OF THE PYLORIC SPHINCTER IN PATIENTS WITH CHRONIC GASTRITIS WITH NORMAL ACIDITY].
    SMOLIGOVETS PV
    Fiziol Zh; 1964; 10():627-35. PubMed ID: 14292126
    [No Abstract]   [Full Text] [Related]  

  • 65. [Octreotide Symposium. 4-5 May 1990, Frankfurt. Proceedings].
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():1-60. PubMed ID: 1980769
    [No Abstract]   [Full Text] [Related]  

  • 66. Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study.
    Qureshi SA; Burch N; Druce M; Hattersley JG; Khan S; Gopalakrishnan K; Darby C; Wong JL; Davies L; Fletcher S; Shatwell W; Sothi S; Randeva HS; Dimitriadis GK; Weickert MO
    BMJ Open; 2016 May; 6(5):e010765. PubMed ID: 27147385
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gall stones and gall bladder motility.
    O'Donnell LJ; Fairclough PD
    Gut; 1993 Apr; 34(4):440-3. PubMed ID: 8491387
    [No Abstract]   [Full Text] [Related]  

  • 68. Effect of chronic octreotide treatment on intestinal absorption in patients with acromegaly.
    Ho PJ; Boyajy LD; Greenstein E; Barkan AL
    Dig Dis Sci; 1993 Feb; 38(2):309-15. PubMed ID: 8425442
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of octreotide on biliary lipid composition and occurrence of cholesterol crystals in patients with acromegaly. A prospective study.
    Erlinger S; Chanson P; Dumont M; Ponsot P; Warnet A; Harris AG
    Dig Dis Sci; 1994 Nov; 39(11):2384-8. PubMed ID: 7956607
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A prospective multicenter octreotide dose response study in the treatment of acromegaly.
    Ezzat S; Redelmeier DA; Gnehm M; Harris AG
    J Endocrinol Invest; 1995 May; 18(5):364-9. PubMed ID: 7594225
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gallstones in acromegalic patients undergoing different treatment regimens.
    Schmidt K; Leuschner M; Harris AG; Althoff PH; Jacobi V; Jungmann E; Schumm-Draeger PM; Rau H; Braulke C; Usadel KH
    Clin Investig; 1992 Jul; 70(7):556-9. PubMed ID: 1356530
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Medical management of acromegaly--what and when?
    Melmed S
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():13-7. PubMed ID: 8372605
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pancreatic exocrine and gallbladder function during long-term treatment with octreotide (SMS 201-995).
    Hopman WP; van Liessum PA; Pieters GF; Smals AG; Tangerman A; Jansen JB; Rosenbusch G; Lamers CB; Kloppenborg PW
    Digestion; 1990; 45 Suppl 1():72-6. PubMed ID: 2185969
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Postprandial exocrine pancreatic function during long-term treatment with the somatostatin analogue SMS 201-995 in acromegalic patients.
    Van Liessum PA; Hopman WP; Pieters GF; Smals AG; Tangerman A; Jansen JB; Rosenbusch G; Lamers CB
    Eur J Clin Invest; 1990 Aug; 20(4):348-53. PubMed ID: 2121494
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly.
    van Liessum PA; Hopman WP; Pieters GF; Jansen JB; Smals AG; Rosenbusch G; Kloppenborg PW; Lamers CB
    J Clin Endocrinol Metab; 1989 Sep; 69(3):557-62. PubMed ID: 2760170
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Postprandial gallbladder motility and plasma cholecystokinin at regular time intervals after injection of octreotide in acromegalics on long-term treatment.
    Hopman WP; Van Liessum PA; Pieters GF; Jansen JB; Lamers CB; Smals AG; Rosenbusch G; Kloppenborg PW
    Dig Dis Sci; 1992 Nov; 37(11):1685-90. PubMed ID: 1425066
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.